Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita.

Altamura, Concetta; Conte, Elena; Campanale, Carmen; Laghetti, Paola; Saltarella, Ilaria; Camerino, Giulia Maria; Imbrici, Paola; Desaphy, Jean-François

Altamura, Concetta; Conte, Elena; Campanale, Carmen; Laghetti, Paola; Saltarella, Ilaria; Camerino, Giulia Maria; Imbrici, Paola; Desaphy, Jean-François.

Afiliación

Altamura C; Dept. of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, Bari, Italy.
Conte E; Dept. of Pharmacy-Drug Sciences, University of Bari Aldo Moro, Bari, Italy.
Campanale C; Dept. of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, Bari, Italy.
Laghetti P; Dept. of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, Bari, Italy.
Saltarella I; Dept. of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, Bari, Italy.
Camerino GM; Dept. of Pharmacy-Drug Sciences, University of Bari Aldo Moro, Bari, Italy.
Imbrici P; Dept. of Pharmacy-Drug Sciences, University of Bari Aldo Moro, Bari, Italy.
Desaphy JF; Dept. of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, Bari, Italy.

Front Pharmacol ; 13: 958196, 2022.

Article en En | MEDLINE | ID: mdl-36034862

Palabras clave

ClC-1 chloride channel; drug repurposing; myotonia congenita; niflumic acid; precision medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Italia